Catalyst Wire Dossier Catalyst Wire Dossier

CVXGA intranasal COVID-19 vaccine

CVXGA · CyanVac LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CVXGA intranasal COVID-19 vaccine, covering 2025-10-20 to 2025-11-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults [Phase 2]

See pricing